维普中文期刊产品整合服务
59篇 您的检索式:作者名="Giorgi U"
    题名 作者 年代 出处 被引量
1High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Work- ing Party显示文摘De Giorgi U Blaise D Lange A 2007Bone Marrow Transplant2007,40,11:1
2Lhermitte's sign followingoxaliplatin-containing chemotherapy in a cisplatin-pretreated ovar-ian cancer patient显示文摘Ciucci G De Giorgi U Leoni M 2003Eur J Neurol2003,10,3:1
3High-dose chemotherapy for triple negative breast cancer显示文摘De Giorgi U Rosti G Frassinetti L 2007Ann Oncol2007,18,1:1
4Circulating tumor eens and fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer 显示文摘De Giorgi U Valero V Rohren E 2009J Clin Oneol2009,27,20:1
5High -dose chemotherapy for triple negative breast cancer显示文摘De Giorgi U Rosti G Fraasineti L 2007Ann Oncol2007,18,1:1
6High-dose chemotherapy for triple negative breast cancer显示文摘GIORGI U D E ROSTI G FRASSINETI L 2007Annals of Oncology2007,18,1:1
7Lhermitte′s sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient显示文摘Ciucci G De Giorgi U Leoni M 2003Eur J Neurol2003,10,3:1
8Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin,preceded by dexrazoxane,and paclitaxel for patients with high-risk Stage Ⅱ-Ⅲ breast cancer显示文摘de Giorgi U Giannini M Frassineti L 0,,04:1
9Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer显示文摘De Giorgi U Valero V Rohren E 2010Ann Oncol2010,21,1:1
10Imatinib and gastrointestinal stromal tumors:Where do we go from here?显示文摘De Giorgi U Verweij J 2005Mol Cancer Ther2005,4,3:1
11Characterization of metastatic breast cancer patientswith nondetectable circulating tumor cells显示文摘MEGO M DE GIORGI U DAWOOD S Int JCancer0,129,2:1
12Imatinib and gastrointestinal stromal tumors : Where do we go from here ? 显示文摘De Giorgi U Verweij J 2005Mol Cancer Ther2005,4,3:1
13Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer显示文摘De Giorgi U Mego M Scarpi E 2012Clin Breast Cancer2012,12,4:1
14Circulating tumor cells and fluorodeoxyglucose positron emission tomography/ computed tomography for outcome prediction in metastatic breast Cancer显示文摘De Giorgi U Valero V Rohren E 2009J Clin Oncol2009,27,20:1
15Circulating tumor cells and bone metastases as detected by FDG-PET/CT inpatients with metastatic breast cancer显示文摘De Giorgi U Valero V Rohren E 2010Ann Oncol2010,21,1:1
16Clinical pharmacology of intraperitoneal cisplatin-based chemotherapy显示文摘Conti M De Giorgi U Tazzari V 2004J Chemother2004,16,:1
1718F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer显示文摘De Giorgi U Mego M Rohren EM 0,,08:1
18Circulating tumor ceils and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer显示文摘De Giorgi U Valero V Rohren E 2010Ann Oncol2010,21,1:1
19Clinical pharmacology of intraperitonealcisplatin-based chemotherapy显示文摘Conti M De Giorgi U Tazzari V 2004Cheother2004,16,5:1
20Effect of an- giosonography to monitor response during imalinib treat- ment in patients with metastatic gastrointestinal sit, mini tu- mors显示文摘De Giorgi U Aliberti C Benea G 2005Clin Cancer Res2005,11,17:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费